Caplin Point Laboratories Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Caplin Point Laboratories Limited with three other
companies in this sector in India:
Mangalam Drugs & Organics Limited
sales of 3.03 billion Indian Rupees [US$46.67 million]
Astec LifeSciences Limited
(3.13 billion Indian Rupees [US$48.30 million]
Astrazeneca Pharma India Ltd
(5.40 billion Indian Rupees [US$83.15 million]
Caplin Point Laboratories Limited reported sales of 4.02 billion Indian Rupees (US$61.89 million)
March of 2017.
increase of 30.2%
versus 2016, when the company's sales were 3.08 billion Indian Rupees.
Sales at Caplin Point Laboratories Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 286%).